Last reviewed · How we verify
NCT04202991
The Relationship Between Pain, Balance and Gait in People With Chronic Obstructive Pulmonary Disease
trial testing Exposure - pain in Chronic Obstructive Pulmonary Disease in 43 participants. Completed in 18 December 2019.
18 December 2019
Quick facts
| Lead sponsor | Teesside University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 43 |
| Start date | 1 May 2019 |
| Primary completion | 18 December 2019 |
| Estimated completion | 18 December 2019 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Exposure - pain
Conditions studied
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
- Balance Impairment — all drugs for Balance Impairment →
- Gait Impairment — all drugs for Gait Impairment →
- Pain — all drugs for Pain →
Sponsor
Teesside University
Who can join
18 and older, any sex, with Chronic Obstructive Pulmonary Disease or Balance Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The balance, gait and pain in Chronic Obstructive Pulmonary Disease (COPD) study will aim to investigate the link between balance and gait impairment, and high rates of pain in people with COPD. This cross-sectional observational study will compare balance and gait outcomes for people with COPD who have pain, to those who are pain free.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04202991
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Obstructive Pulmonary Disease
Currently open trials in the same condition.
- NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
- NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
- NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
- NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting
Other Teesside University trials
Trials by the same sponsor.
- NCT07510230 — Media Orientation to Improve Childhood Vaccine Uptake and Address Parent and Caregivers Vaccine-related Anxiety: A Pilot · NA · not yet recruiting
- NCT07251478 — Transparent Communication to Improve Mental Wellbeing and Attitude Towards Reintegration · NA · not yet recruiting
- NCT06998602 — Student Paramedics' Experiences of Compassion Fatigue: a Phenomenological Mixed-methods Study · completed
- NCT06628518 — FAmily Oriented Mindfulness Informed Legal Education (FAMiLE) Programme for Parent or Carers Affected by Incarceration a · NA · not yet recruiting
- NCT06601023 — Problem Management Plus Mindfulness-informed Legal Education for Addressing Gender-based Violence and Improving Parentin · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04202991 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Teesside University
- Last refreshed: 27 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04202991.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing